entity

EPIGALLOCATECHIN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about EPIGALLOCATECHIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9Connections
0Hypotheses
0Analyses
7Outgoing
2Incoming
0Experiments

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

therapeutic · 6350 words

Alpha-Synuclein Pathology

mechanism · 6288 words

Section 162: Advanced Antioxidant and Redox Therapy in CBS/PSP

therapeutic · 5600 words

Synucleinopathy Mechanism

mechanism · 4870 words

Outgoing (7)

TargetRelationTypeStr
PARKINSON'S DISEASEimplicated_indisease0.55
KEAP1associated_withgene0.45
NRF2associated_withgene0.45
PARKINSONassociated_withdisease0.45
PARKINSON'S DISEASEassociated_withdisease0.45

Incoming (2)

SourceRelationTypeStr
CREBassociated_withgene0.45
CURCUMINassociated_withdrug0.45

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found